非接触心内膜激动标测系统指导房间隔缺损修补术后Ⅱ型心房扑动的射频消融(附一例报道)

评价非接触球囊导管标测系统 (EnSite 30 0 0 )在指导房间隔缺损 (ASD)修补术后心房扑动 (简称房扑 )的射频消融中的临床应用。 1例女性患者 ,41岁 ,ASD修补术后 2 2年开始频繁发作心动过速 ,体表心电图示Ⅱ型房扑。应用EnSite 30 0 0构建右房三维几何模型 ,标测心动过速的折返激动顺序 ,发现手术疤痕与三尖瓣环之间、下腔静脉与三尖瓣环之间为折返环路的关键峡部 ,应用导航系统指导峡部消融 ,成功阻断心动过速 ;消融后通过起搏标测判定峡部已达完全双向阻滞。随访 2 0个月 ,无心动过速复发。结论 :在ASD修补术后房扑的标测和消融中应用EnSite30 0 0系统是安全有效的 ,不仅能确定折返环路的关键峡部 ,而且能准确判断线性损伤的连续性。     

非接触心内膜激动标测系统指导房间隔缺损修补术后H型心房扑动的射频消融（附一例报道）

评价非接触球囊导管标测系统(EnSite 3000)在指导房间隔缺损(ASD)修补术后心房扑动(简称房扑)的射频消融中的临床应用。1例女性患者，41岁，ASD修补术后22年开始频繁发作心动过速，体表心电图示H型房扑。应用EnSite 3000构建右房三维几何模型，标测心动过速的折返激动顺序，发现手术疤痕与三尖瓣环之间、下腔静脉与三尖瓣环之间为折返环路的关键峡部，应用导航系统指导峡部消融，成功阻断心动过速；消融后通过起搏标测判定峡部已达完全双向阻滞。随访20个月，无心动过速复发。结论：在ASD修补术后房扑的标测和消融中应用EnSite 3000系统是安全有效的，不仅能确定折返环路的关键峡部，而且能准确判断线性损伤的连续性。     

非接触标测对于典型心房扑动的标测、消融和电生理机制的新认识

目的介绍非接触标测对于典型心房扑动(简称房扑,AFL)的标测、消融和电生理机制的新认识.方法 9例典型AFL,男性7例,女性2例.使用非接触标测对窦律时峡部的双向传导、AFL时的折返激动序列进行详细标测,在导航系统指导下完成后位峡部线性消融,然后验证峡部双向传导阻滞.结果 (1)1例为顺钟向AFL,7均为逆钟向AFL,1例未能诱发AFL,所有AFL平均心房心动周期(215±36)ms;(2)非接触标测三维显示AFL在右房内的整个折返环及其与解剖结构的三维关系;(3)激动可以穿过界嵴上部并且传导相对缓慢,提示右心房平滑部是折返环的一部分;(4)非接触标测可直观显示复发病例的消融线缺口,并直接导航消融;(5)1例术中出现心房颤动,1例因不能耐受消融所致胸痛放弃手术,其余7例即刻均达到峡部双向阻滞,随访12～36月未见复发.结论非接触标测系统可直观再现典型AFL的完整折返环及其与右房解剖结构的关系,确认折返机制,对复发病例可发现消融线裂隙并导航消融.同时发现激动可横向穿过界嵴并且速度缓慢.     

非接触标测系统用于典型心房扑动的右房标测和导航消融

应用非接触标测系统实施典型心房扑动 (AFL)的右房 (RA)全心腔标测和导航射频消融。 6例典型AFL ,男 5例、女 1例 ,年龄 5 6 .2± 15 .3(35～ 76 )岁。常规放置冠状静脉窦和His束电极 ,将标测球囊置于RA中下部 ,构建RA心内膜模型 ,分别于低位RA和冠状窦口 (CSO)S1S16 0 0ms起搏观察峡部传导 ,诱发并标测AFL的激动顺序和折返路径。 1例为顺钟向AFL ,4例为逆钟向AFL ,1例未能诱发AFL。AFL周期 2 0 7± 34ms,非接触标测可显示整个折返环路、激动顺序和缓慢传导区。AFL的激动可以穿过界嵴上部并且传导相对缓慢 ,提示RA平滑部是折返环的一部分。后位峡部线性消融在导航系统指导下进行 ,无需X线透视。消融完成后重复上述起搏验证峡部双向传导阻滞。除 1例术中出现心房颤动 (AF)外 ,其余病例即刻均达到峡部双向阻滞 ,未出现其他并发症 ,随访 8.1± 6 .7(3～15 )个月未见复发。非接触标测系统可安全、有效和直观地实现典型AFL的右房全心腔标测并导航消融 ,验证峡部双向阻滞 ,减少X线曝光时间和无效放电次数。界嵴在典型AFL时具备传导功能 ,RA平滑部和粗糙部共同参与折返环的组成。     

大折返房性心动过速的电解剖标测和导管射频消融

目的应用电解剖标测系统分析3例大折返房性心动过速(房速)的电生理机制并导航消融。方法3例房速患者(男1例,女2例),平均年龄51±12岁,心动过速病史19±11年。常规电生理检查初步确定房速所在心腔,使用电解剖标测系统构建心房三维模型,完成电压和激动标测,分析心动过速的机制并确定缓慢传导区(即关键峡部),使用冷生理盐水灌注导管消融。结果3例患者临床常规检查初步排除结构性心脏病,电压标测均显示被标测心房存在疤痕区。病例1为围绕三尖瓣环顺钟向的大折返房速,关键峡部位于三尖瓣环与后侧壁的疤痕之间。病例2为围绕上腔静脉逆钟向的大折返房速,关键峡部位于右房侧壁疤痕与上腔静脉之间。病例3为左房8字形折返,关键峡部位于左房顶部的两片疤痕之间。3例患者均在关键峡部消融成功,随访9～10个月未见复发。结论电解剖标测可以揭示大折返房速的基质,阐明折返机制,并有效指导消融。     

应用非接触球囊导管标测系统指导心动过速的心内膜标测与消融

目的观察非接触球囊导管标测系统指导难治性室性心动过速的标测与射频消融的有效性和优越性。方法5例患者均为男性，平均年龄33.2岁。经股静脉或股动脉置入64极球囊电极和射频消融导管至同一心室，计算机标测系统首先构建心腔的几何构型，然后建立心动过速的腔内等电势图，分析心动过速的最早起源点及折返激动的关键峡部，最终利用计算机导航系统指导消融导管至拟定靶点处进行环状或线形消融。结果5例患者共诱发出6种心动过速，心动过速平均周期为（336.6±42.7）ms。2例特发性左室室性心动过速及1例隐匿性束室纤维患者均消融成功。1例扩张型心肌病患者共有两种心动过速，一种起源于右室流出道，另一种起源于左室间隔部，前者消融成功，后者因导管操作致心动过速持续发作伴血流动力学不稳定而终止手术。1例致心律失常性右室心肌病患者于最早激动点处做环状消融，未获成功。5例患者术中和术后均无并发症发生。随访4个月，所有消融成功患者均未再有心动过速发作。结论非接触性球囊导管标测系统指导心律失常的心内膜标测与消融是安全、有效的，与常规的标测和消融方法比较，该系统有一定的优越性，尤其适用于复杂病例、血流动力学不稳定和非持续性室性心律失常的标测及指导射频消融。     

特发性左室室性心动过速非接触球囊导管系统的标测与消融

介绍非接触球囊导管标测系统 (EnSite 30 0 0系统 )指导难治性特发性左室室性心动过速的标测与射频消融的初步经验。 5例男性病人 ,年龄 33± 17(17～ 6 2 )岁 ,常规方法标测和导管消融失败 2 .4± 1.1(1～ 4)次。常规放置高位右房和右室电生理导管 ,运用置入左室的 6 4极球囊导管和大头电极 ,系统重建三维心内膜几何模型和等电势 ,经右室导管诱发VT ,心动过速周期为 32 3.8± 48.1ms。EnSite 30 0 0系统标测到VT的最早激动点分别位于左后间隔中下部、左侧间隔后下部左束支下方、后下间隔近心尖部、左室后壁近基底部和左后间隔中部。在最早激动点和关键峡部分别行点状、环状和线性消融。 2例患者在心动过速时放电、3例患者在窦性心律时消融 ,均获成功。成功消融靶点处的单极电图均为QS型。X线曝光时间为 2 5± 12min。随访 7.8± 4.6 (1～ 11)个月所有患者均未发作心动过速。结果表明 ,与常规方法比较 ,EnSite 30 0 0系统所建立的心腔三维模拟等电势图可直观地显示心动过速的起源点、传导途径和关键峡部 ,系统模拟的单极腔内电图的形态也有助于判断病灶起源部位及提高消融成功率 ,尤其适用于常规方法消融失败的室性心律失常的标测 ,其独特的导航系统可引导消融导管到达靶点部位指导射频消融 ,并可减少X?     

典型心房扑动的经导管射频消融治疗

回顾分析 35例典型心房扑动 (简称房扑 )患者电生理检查和射频消融治疗的临床结果。心内激动标测显示沿三尖瓣环 (TA)逆钟向折返性房扑 2 7例 ,顺钟向折返 2例 ,同时存在二种折返 6例。 8例行TA峡部拖带起搏者均呈隐匿性拖带 ,起搏后间期与房扑周长差值为 1± 4(- 3～ 5 )ms。采用TA峡部双线性消融、后峡部或 /和间隔峡部消融的方法治疗所有患者均成功。 15例以房扑不能再诱发为手术终点 ,随访 10例 ,3例复发 ,复发率 30 % ;2 0例达到TA峡部双向阻滞 ,随访 19例 ,1例复发 ,复发率 5 % ,两组比较P <0 .0 5。随访的 2 9例中 ,7例发生心房颤动 (简称房颤 ) ,发生率 2 4%。与无房颤发作者相比 ,合并器质性心脏病、心房扩大和有房颤病史者的比例明显增加 (6 / 7比 9/ 2 2 ,6 / 7比 4/ 2 2和 7/ 7比 2 / 2 2 ,均P <0 .0 5 )。结果表明 ,心内激动标测结合拖带起搏技术可确定典型房扑的诊断 ,后峡部或间隔峡部消融是治疗房扑的有效方法 ,以TA峡部双向阻滞为手术终点较房扑不能被再诱发为终点可明显降低复发率。房扑消融术后发生房颤与合并器质性心脏病、心房扩大和术前存在房颤有关     

动态基质标测在致心律失常右室心肌病患者室性心动过速射频消融中的应用

目的　探讨应用非接触球囊导管标测系统行动态基质标测,指导对致心律失常右室心肌病(ARVC)患者室性心动过速(室速)消融的价值。方法　应用非接触球囊导管标测系统在窦律下对 3例ARVC室速患者行动态基质标测,在确定室速的最早激动点、出口部位和传导顺序后,寻找与室速相关的峡部并行线性消融。结果　3例患者存在 3种不同形态的基质,分别位于右室流出道、右室前壁和右室前侧壁。共诱发 5种室速,平均心动周期为(348±65)ms,其中 3种室速起源于基质或基质边缘, 2种室速的起源远离基质; 1种室速经基质传导。5种室速全部消融成功。平均随访 20个月,无心动过速发作。结论　应用非接触球囊导管标测系统确定异常电生理基质有助于理解ARVC室速的发生机制和制定消融策略,行室速相关峡部的线性消融可有效治疗室速。     

心房内双环折返性心动过速的非接触球囊导管标测及射频消融

目的 阐明心房内双环折返性心动过速的电生理机制及导管射频消融的技术。方法 3例患，均为女性，年龄41-66岁，心动过速病史6个月-10年，例1为先天性心脏病房间隔缺损修补术后，例2为特发性心动过速，例3为扩张型心肌病，经左股静脉置入9F球囊电极至右心房中部并展开，球囊中心位于希氏束和冠状静脉窦口中间，进入球囊时，静脉注射肝素100U/kg，并保持手术过程中活化的血小板凝结时间（ACT）位于250s左右，以后经右股静脉进入8F消融导管构建右心房三维几何构型，构型构建完毕后，经高位右心房诱发心动过速，建立心动过速的腔内等电势图，然后分析心动过速的起源，折返激动的环路，传导方向，关键峡部，由此确定线性消融的部位和起止点，经导航系统引导消融导管至拟订靶点处，每点予以60W，60s,60℃温控消融，直至产生消融线径的双向阻滞。结果 3例患均有心房内双环折返性房性心动过速（房速），折返环分别围绕三尖瓣环和病变组织周围，于各自的峡部行线性消融产生双向阻滞后，心动过速不再诱发，随访分别为3、5和12个月，无心动过速复发，例2术后动态心电图记录有频繁房性早搏，部分房性早搏触发短阵心房颤动。结论 心房内存在病变组织如手术瘢痕，补片及梗死病灶时可产生心房内折返，若合并围绕三尖瓣环折返的典型心房扑动则形成心房内双环折返性房速。双环折返性房速也可发生在无器质性心脏病的患，不同的基础心脏病变决定着不同的折返环路和折返方式，双环折返性房速存在两个关键峡部，需要两次线性消融才可阻止心动过速的发生，非接触球囊导管标测系统（EnSite3000)不同可破译心房内双环折返性心动过速的电生理机制，也为其消融方法提供可靠的策略。     

Open-window mapping of accessory pathways utilizing high-density mapping

Journal of Interventional Cardiac Electrophysiology - Accessory pathway (AP) mapping is currently based on point-by-point mapping and identifying if a local electrogram’s origin is atrial,...     

Phylogenetic fate mapping

Cell fate maps describe how the sequence of cell division, migration, and apoptosis transform a zygote into an adult. Yet, it is only in Caenorhabditis elegans where microscopic observation of each cell division has allowed for construction of a complete fate map. More complex, and opaque, animals prove less yielding. DNA replication, however, generates somatic mutations. Consequently, multicellular organisms comprise mosaics where most cells acquire unique genomes that are potentially capable of delineating their ancestry. Here we take a phylogenetic approach to passively retrace embryonic relationships by deducing the order in which mutations have arisen during development. We show that polyguanine repeat DNA sequences are particularly useful genetic markers, because they frequently change length during mitosis. To demonstrate feasibility, we phylogenetically reconstruct the lineage of cultured mouse NIH 3T3 cells based on mutations affecting the length of polyguanine markers. We then employ whole genome amplification to genotype polyguanine markers in single cells taken from a mouse and use phylogenetics to infer the developmental relationships of the sampled tissues. The result is consistent with the present understanding of embryogenesis and demonstrates the large scale potential of this method for producing a complete mammalian cell fate at the resolution of a single cell.     

Epicardial isopotential mapping from body surface isopotential mapping in myocardial infarction

It is useful to construct the epicardial isopotential mapping (the Ep Map) from the body surface isopotential mapping (the Body Map) for clinical diagnosis of cardiac disease, even though there are many unsolved problems in using the inverse solution. Yamashita et al. carried out this solution by using the finite element technique. In the present study, the clinical value of that method has been investigated in cases of myocardial infarction. The Ep Maps at 20, 25 and 30 msec. from the beginning of the QRS complex were obtained from the Body Map at the same time by using that method; the infarcted areas on the Ep Map were determined by using Toyama's method which was reported in a previous study. The infarcted area at 30 msec. on the Ep Map was located at the anterior wall along the ventricular septum in anterior infarction and at the posterior wall of the left ventricle in inferoposterior infarction. Patients were independently examined with the scintigram with thallium-201 and the infarcted area was coincident to the location of the abnormal findings of the scintigram. Moreover, the size of the infarcted area on the Ep Map and the size of the abnormal findings of the scintigram were parallel in most cases except one.     

非接触球囊导管标测系统指导心律失常的心内膜标测和导航消融

目的:观察非接触球囊导管标测系统指导疑难心律失常的标测与射频消融的有效性与优越性。方法:6例患者,男5例,女1例,年龄28~50(36.2±12.3)岁。电生理检查为右室特发性室性期前收缩1例,左房房性心动过速1例,右房房性心动过速2例,左房心房颤动2例。其中3例常规电生理标测消融未获成功。经股静脉置入64极球囊电极和射频消融导管至同一心腔,计算机标测系统首先构建心腔几何构型,然后建立心动过速的腔内等电势图,分析心动过速的起源点及关键峡部,利用计算机导航系统指导消融导管至拟定靶点处进行消融。结果:1例起源于右室流出道偏间隔的室性期前收缩患者行片状消融获得成功,1例左房房性心动过速标测其心动过速起源于右肺下静脉间隔部,并指引消融导管行右肺下静脉至二尖瓣之间线性消融获得成功,2例右房房性心动过速中1例标测其最早激动点位于下腔静脉口,此处行环状消融获得成功,另1例位于上腔静脉后方穿过界嵴中部线性消融获得成功。2例左房心房颤动患者,1例在窦性心律下其致心房颤动房性期前收缩起源于左右上肺静脉之间,行线性消融成功;另1例在心房颤动持续发作下行左上下肺静脉环状消融及左右上肺静脉间线性消融成功。6例患者术中、术后均无并发症发生,随访4~13个月,无一例复发。结论:非接触球囊导管标测指导心律失常的心内膜标测与消融是安全有效的,对复杂、难治性心律失常的电生理机制的阐明和指导消融具有较好的临床应用价值。     

Body surface isopotential mapping system by colored spatial mapping electrocardiography]

We developed a new body surface isopotential mapping system using a colored spatial mapping electrocardiographic technique based on Frank's vectorcardiography to be used with CERX CQ-3011 and NEC PC-100 computers. We assessed its usefulness in comparison with the conventional body surface mapping technique in 12 patients with old myocardial infarction (6 with anterior and 6 with inferior infarction), and in 10 healthy subjects. All distributions of positive and negative zones presented on body surface isopotential maps were obtained with this new technique, which corresponded well with the distribution of zones on conventional body surface isopotential maps. Although the maximum and minimum positions of the 2 maps did not coincide with one another, this new map aided in diagnosing anterior and inferior infarction from the minimum position determined 20 msec after the onset of QRS. This new mapping system allows a clear spatial representation of vectorcardiograms and requires less complicated procedure compared with the conventional body surface mapping technique. Thus, this body surface isopotential mapping system should be clinically useful.     

Endocardial mapping of right ventricular outflow tract tachycardia using noncontact activation mapping

INTRODUCTION: Activation mapping and pace mapping identify successful ablation sites for catheter ablation of right ventricular outflow tract (RVOT) tachycardia. These methods are limited in patients with nonsustained tachycardia or isolated ventricular ectopic beats. We investigated the feasibility of using noncontact mapping to guide the ablation of RVOT arrhythmias. METHODS AND RESULTS: Nine patients with RVOT tachycardia and three patients with ectopic beats were studied using noncontact mapping. A multielectrode array catheter was introduced into the RVOT and tachycardia was analyzed using a virtual geometry. The earliest endocardial activation estimated by virtual electrograms was displayed on an isopotential color map and measured 33 +/- 13 msec before onset of QRS. Virtual unipolar electrograms at this site demonstrated QS morphology. Guided by a locator signal, ablation was performed with a mean of 6.9 +/- 2.2 radiofrequency deliveries. Acute success was achieved in all patients. During follow-up, one patient had a recurrence of RVOT tachycardia. Compared with patients (n = 21) who underwent catheter ablation using a conventional approach, a higher success rate was achieved by noncontact mapping. Procedure time was significantly longer in the noncontact mapping group. Fluoroscopy time was not significantly different in the two groups. CONCLUSION: Noncontact mapping can be used as a reliable tool to identify the site of earliest endocardial activation and to guide the ablation procedure in patients with RVOT tachycardia and in patients with ectopic beats originating from the RVOT.     

Body surface potential mapping for mapping and treatment of persistent atrial fibrillation

Techniques facilitating individual mapping and ablation of arrhythmogenic substrates are desired to enhance our understanding of persistent atrial fibrillation (persAF) mechanisms as a prerequisite to increasing the success rates of single procedure persAF catheter ablation. The technique of body surface potential mapping (BSM) involves the use of multiple electrodes to collect the potentials over a large body surface area and, with the use of a computed tomography scan, it facilitates their correlation to a 3D model of the atrial structures. During AF,the visualization and localization of AF driver activity, both reentrant and focal wavefronts, is possible with this technique. The ECVUE system from CardioInsight was examined for this indication in clinical studies and showed a termination rate of persAF of 63?% in a large multicenter trial (AFACART) with a promising low recurrence rate during follow-up. From our initial experience, the system appears to be effective in persAF patients who have continuous AF for less than ?1 year. However, the utility of the system for highly challenging cases like long-standing persistent AF and patients with very short AF cycle length remains to be explored. Further studies are needed to confirm these data and answer the multitude of open questions in this field.     

Information-based functional brain mapping

The development of high-resolution neuroimaging and multielectrode electrophysiological recording provides neuroscientists with huge amounts of multivariate data. The complexity of the data creates a need for statistical summary, but the local averaging standardly applied to this end may obscure the effects of greatest neuroscientific interest. In neuroimaging, for example, brain mapping analysis has focused on the discovery of activation, i.e., of extended brain regions whose average activity changes across experimental conditions. Here we propose to ask a more general question of the data: Where in the brain does the activity pattern contain information about the experimental condition? To address this question, we propose scanning the imaged volume with a "searchlight," whose contents are analyzed multivariately at each location in the brain.     

Functional connectivity density mapping

Brain networks with energy-efficient hubs might support the high cognitive performance of humans and a better understanding of their organization is likely of relevance for studying not only brain development and plasticity but also neuropsychiatric disorders. However, the distribution of hubs in the human brain is largely unknown due to the high computational demands of comprehensive analytical methods. Here we propose a 10³ times faster method to map the distribution of the local functional connectivity density (lFCD) in the human brain. The robustness of this method was tested in 979 subjects from a large repository of MRI time series collected in resting conditions. Consistently across research sites, a region located in the posterior cingulate/ventral precuneus (BA 23/31) was the area with the highest lFCD, which suggest that this is the most prominent functional hub in the brain. In addition, regions located in the inferior parietal cortex (BA 18) and cuneus (BA 18) had high lFCD. The variability of this pattern across subjects was <36% and within subjects was 12%. The power scaling of the lFCD was consistent across research centers, suggesting that that brain networks have a “scale-free” organization.